Sponsor

Centre Hospitalier Sud Francilien

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Centre Hospitalier Sud Francilien appears in 26 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials26
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

26 shown
Hybrid Closed-Loop Insulin Delivery After PancreatectomyNCT07430293 · lead sponsor · 2026-05-19
RECRUITING
Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose MeasurementNCT06192940 · lead sponsor · 2024-03-28
RECRUITING
Combination of High-flow Nasal Oxygen (Optiflow) and Vibrating Membrane Nebuliser (Aerogen) in the Pre-hospital Setting - Before/After StudyNCT07791992 · lead sponsor · 2026-10-01
WITHDRAWN
Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late OnsetNCT05808309 · lead sponsor · 2025-05-28
WITHDRAWN
Association Between CGM Metrics in Type 2 Diabetes Pregnancy and Perinatal MorbidityNCT06892314 · lead sponsor · 2025-05-15
COMPLETED
Long-term Observation Of Patient Engagement in Automated Insulin DeliveryNCT06858475 · lead sponsor · 2025-03-20
COMPLETED
Exome Evaluation in Patients Living With Diabetes Complicated by Charcot Neuroarthropathy.NCT06096935 · lead sponsor · 2024-07-11
COMPLETED
Hybrid Closed Loop Insulin Pump and Bariatric Surgery in Patients With Type 1 DiabetesNCT06294704 · lead sponsor · 2024-04-23
COMPLETED
Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-FranceNCT06336577 · lead sponsor · 2024-03-28
COMPLETED
Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age with Type 1 DiabetesNCT06253351 · lead sponsor · 2024-03-13
COMPLETED
Closed-loop Insulin Delivery Systems in Pancreatic DiabetesNCT06227650 · lead sponsor · 2024-02-06
COMPLETED
Comparison With Observational Methods and Performance Assessment From Real-life Experience of Closed-Loop Insulin Delivery SystemsNCT05932966 · lead sponsor · 2023-07-06
COMPLETED
Safety of Closed-loop Hybrid Insulin Administration During Ramadan Fasting in People Living With Type 1 DiabetesNCT05747352 · lead sponsor · 2023-06-05
COMPLETED
Closed-Loop Insulin Delivery During Pregnancy (IADIABENCEINTE)NCT05661149 · lead sponsor · 2023-05-11
COMPLETED
Real-life Efficacy of Insulia® Tool in Patients Living with Type 2 Diabetes Treated with Basal Insulin Therapy As Part of a National Telemedicine Program (ETAPES)NCT05331339 · lead sponsor · 2022-11-02
COMPLETED
It is Possible to Maintain the Performance of Screening Colonoscopies Under MEOPA During the Covid 19 Epidemic Period When Access to the Operating Room is LimitedNCT05336617 · lead sponsor · 2022-05-13
COMPLETED
Acceptability of Hybrid Closed-loop Systems in Patients Living With Highly Unbalanced Type 1 DiabetesNCT05282264 · lead sponsor · 2022-04-01
COMPLETED
Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II DiabetesNCT04893135 · lead sponsor · 2021-10-11
COMPLETED
Study of Insulin Pump Discontinuation in Adults With DiabetesNCT04915066 · lead sponsor · 2021-06-29
COMPLETED
Study of the Effect of Telemedicine on Glycemic Control for Patients With Diabetes and Treated With InsulinNCT04883372 · lead sponsor · 2021-05-22
COMPLETED
Post-healing Follow-up Study in People With Remission of a Diabetic Foot UlcerNCT04892771 · lead sponsor · 2021-05-20
COMPLETED
COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-managementNCT04669912 · lead sponsor · 2021-01-15
COMPLETED
Evaluation of Iodine Supplementation in Women With Pregnancy Associated With Gestational DiabetesNCT04683211 · lead sponsor · 2021-01-05
COMPLETED
MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISENCT03437018 · lead sponsor · 2019-10-10
COMPLETED
Comparison of Cardiac Rehabilitation Benefits Between Coronary and Non-coronary Patients Through a 24 Months Follow-up After Myocardial Infarction: the "INCARD" StudyNCT01683903 · lead sponsor · 2012-08-01
UNKNOWN
Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 DiabetesNCT03184662 · collaborator · 2018-02-12
TERMINATED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Centre Hospitalier Sud Francilien as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor25
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.